Calcium Competitive Inhibition of Langerin by Thiazolopyrimidinones
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.5c01756 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Yunzhan Ning und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, Vienna 1090, Austria. Hauptthemen laut MEDLINE: Lectins, C-Type, Mannose-Binding Lectins, Calcium, Antigens, CD. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, Austrian Science Fund, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
C-Type lectins are a large family of carbohydrate-binding proteins. Langerin is a member of this family and is expressed by Langerhans cells, involved in pathogen recognition and innate immune activation, making it a target for small-molecule modulation in immunology and infectious diseases. We previously identified thiazolopyrimidinones as a series of allosteric inhibitors, but the underlying mechanism remained unclear. In this study, 43Ca NMR demonstrated that these fragments induce Ca2+ release from the receptor. Our ITC data suggested a competitive relationship between inhibitors and Ca2+, which was further validated by 19F NMR spectroscopy showing inhibition of carbohydrate binding. Surprisingly, the fragment binding site was found to be located beneath the long loop, which supports the dynamic nature of the long loop being highly Ca2+ dependent. Our findings provide insight into the novel Ca2+-competitive inhibitory mechanism of murine langerin and are the first report on such an inhibitory mechanism for a C-type lectin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, Vienna 1090, Austria.
- Vienna Doctoral School of Pharmaceutical, Nutritional and Sport Sciences, University of Vienna, Josef-Holaubek-Platz 2, Vienna 1090, Austria.
- Department of Chemical Biology, Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Str. 10, Berlin 13125, Germany.
- Institute of Biological Chemistry, Faculty of Chemistry, University of Vienna, Vienna 1090, Austria.
- University of Vienna, Währinger Straße 38, Vienna 1090, Austria.
- Institute of Food Chemistry, Leibniz University Hannover, Callinstraße 5, Hannover 30167, Germany.
ORCID-Profile: Yunzhan Ning, Jonathan Lefèbre, Max Ruwolt, Maurice Besch, Bernhard Loll, Dennis Kurzbach, Marc Nazaré, Christoph Rademacher
Förderung
- Austrian Science Fund FWF
- Austrian Science Fund
- Deutsche Forschungsgemeinschaft
- China Scholarship Council
Zitieren
APA
Ning, Y., Efrém, N. L., Amoussa, M., Turhan, E., Zheng, D., Lefèbre, J., Ruwolt, M., Neu, U., Besch, M., Loll, B., Kurzbach, D., Köhnke, J., Nazaré, M., & Rademacher, C. (2025). Calcium Competitive Inhibition of Langerin by Thiazolopyrimidinones. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c01756
Vancouver
Ning Y, Efrém NL, Amoussa M, Turhan E, Zheng D, Lefèbre J, et al. Calcium Competitive Inhibition of Langerin by Thiazolopyrimidinones. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c01756
BibTeX
@article{Ning2025,
author = {Ning, Yunzhan and Efrém, Nina-Louisa and Amoussa, Machoud and Turhan, Ertan and Zheng, Dazhong and Lefèbre, Jonathan and Ruwolt, Max and Neu, Ursula and Besch, Maurice and Loll, Bernhard and Kurzbach, Dennis and Köhnke, Jesko and Nazaré, Marc and Rademacher, Christoph},
title = {Calcium Competitive Inhibition of Langerin by Thiazolopyrimidinones},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.5c01756}
}
EUVIMED